Skip to main content
Smart Investors Daily
XA

NASDAQ · XAGEW

Longevity Health Holdings Inc.

Healthcare · Biotechnology

$0.01

Down-$0.00 (-1.96%)

Updated Nov 5, 2026, 11:57 AM

SID Score

—

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
8.99K
P/E ratio
-0.13
Dividend yield
0.00%
52-week range
— – —
Volume
16.1K
Avg. volume
25.82K

Price performance · XAGEW

XAGEW price history

1M range · 0 trading sessions · Daily adjusted prices

XAGEW does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest XAGEW news

The latest Smart Investors Daily articles mentioning XAGEW.

XAGEW research

Overview

Company profile and research snapshot.

Company profile

LONGEVITY HEALTH HLDGS WT

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 18, 2026

PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings

Binding, interest-bearing payment plan converts PMGC’s 5% net sales royalty into scheduled monthly cash payments to NorthStrive Biosciences through August 2031, creating recurring, non-dilutive cash flowAgreement covers the 2025 royalty and all future royalty and earnout payments, backed by joint and several obligors, mandatory prepayments tied to Longevity capital events, and annual audit rights NEWPORT BEACH, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (“PMGC” or the “Company

Yahoo · Sep 8, 2026

Longevity Health Holdings Enters into Securities Purchase Agreement for Up to $625,000 in Gross Proceeds

Company draws initial $375,000 tranche from institutional investor Puritan PartnersPITTSBURGH, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (OTCQB: XAGE) (“Longevity” or the “Company”) today announced that it has entered into a Securities Purchase Agreement with Puritan Partners LLC (“Puritan”) providing for up to $625,000 in aggregate gross proceeds to the Company through a series of 10% senior secured convertible notes, each issued with a 10% original issue discount (the

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.